Latest Programmed cell death Stories
Unique delivery vehicle to be developed across p53 mutated solid tumors by delivering wild type p21 NEW YORK and ZUG, Switzerland, April 15, 2015 /PRNewswire/ -- SELLAS Life Sciences
Ubiquitin system produces a protein that greatly restricts the development of cancerous tumors NEW YORK, April 10, 2015 /PRNewswire-USNewswire/ -- A new study by researchers at the
Cancer research has truly gone to the dogs as scientists at the University of Illinois have announced the start of phase I trials for a drug showed good results in the treatment of spontaneously occurring cancers in pet dogs.
Georgia State University has signed a license agreement with Cisen Pharmaceutical Co.
UC Davis researchers have uncovered a complex interaction between the proteins Rbm38 and p53 that governs tumor suppression and aging Sacramento, Calif.
A University of Colorado Cancer Center study being presented at the San Antonio Breast Cancer Symposium shows that triple negative breast cancer cells process tryptophan to promote survival while
SAN DIEGO, Dec.
New Assay Critical to the Study of the Human Immune Responses and Cancers. State College, PA (PRWEB) October 17, 2014 INDIGO Biosciences, a leading provider
Researchers have identified a molecule that blocks the activity of a disease-causing enzyme – a breakthrough that could ultimately lead to the development of a wonder drug that could be used to fight many different diseases.
CHARGE, which affects 1 in 10,000 babies, is an acronym whose letters stand for some of the more common symptoms of the condition: coloboma of the eye, heart defects, atresia of the choanae, retardation of growth and/or development, genital and/or urinary abnormalities, and ear abnormalities and deafness.
- Emitting flashes of light; glittering.